Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN1445224A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1445224A details a novel Ru-catalyzed asymmetric transfer hydrogenation process for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.